Secondary use of clinical data: The Vanderbilt approach

被引:191
作者
Danciu, Ioana [1 ,2 ]
Cowan, James D. [1 ]
Basford, Melissa [1 ]
Wang, Xiaoming [1 ]
Saip, Alexander [1 ]
Osgood, Susan [1 ]
Shirey-Rice, Jana [1 ]
Kirby, Jacqueline [1 ]
Harris, Paul A. [1 ,2 ]
机构
[1] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Clin & Translat Res, Nashville, TN 37203 USA
[2] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN 37232 USA
关键词
Biomedical informatics; Secondary use of clinical data; Research data warehouse; Research enterprise; ELECTRONIC MEDICAL-RECORDS; GENOME-WIDE ASSOCIATION; DNA BIOBANK; OPT-OUT; PERSONALIZED MEDICINE; EMERGE NETWORK; HEALTH RECORDS; GENETIC RISK; PRIVACY; INFORMATION;
D O I
10.1016/j.jbi.2014.02.003
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
The last decade has seen an exponential growth in the quantity of clinical data collected nationwide, triggering an increase in opportunities to reuse the data for biomedical research. The Vanderbilt research data warehouse framework consists of identified and de-identified clinical data repositories, fee-for-service custom services, and tools built atop the data layer to assist researchers across the enterprise. Providing resources dedicated to research initiatives benefits not only the research community, but also clinicians, patients and institutional leadership. This work provides a summary of our approach in the secondary use of clinical data for research domain, including a description of key components and a list of lessons learned, designed to assist others assembling similar services and infrastructure. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:28 / 35
页数:8
相关论文
共 116 条
[1]   Data Re-Identification: Societal Safeguards [J].
Altman, Russ B. ;
Clayton, Ellen Wright ;
Kohane, Isaac S. ;
Malin, Bradley A. ;
Roden, Dan M. .
SCIENCE, 2013, 339 (6123) :1032-1033
[2]  
Ancker Jessica S, 2011, AMIA Annu Symp Proc, V2011, P57
[3]  
[Anonymous], 2013, IBM NETEZZA 1000 US
[4]   Mapping genes that predict treatment outcome in admixed populations [J].
Baye, T. M. ;
Wilke, R. A. .
PHARMACOGENOMICS JOURNAL, 2010, 10 (06) :465-477
[5]   Evaluating re-identification risks with respect to the HIPAA privacy rule [J].
Benitez, Kathleen ;
Malin, Bradley .
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2010, 17 (02) :169-177
[6]   The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients [J].
Birdwell, Kelly A. ;
Grady, Ben ;
Choi, Leena ;
Xu, Hua ;
Bian, Aihua ;
Denny, Josh C. ;
Jiang, Min ;
Vranic, Gayle ;
Basford, Melissa ;
Cowan, James D. ;
Richardson, Danielle M. ;
Robinson, Melanie P. ;
Ikizler, Talat Alp ;
Ritchie, Marylyn D. ;
Stein, Charles Michael ;
Haas, David W. .
PHARMACOGENETICS AND GENOMICS, 2012, 22 (01) :32-42
[7]  
Botsis Taxiarchis, 2010, Summit Transl Bioinform, V2010, P1
[8]  
Brothers Kyle B, 2012, AJOB Prim Res, V3, P21
[9]   Two large-scale surveys on community attitudes toward an opt-out biobank [J].
Brothers, Kyle B. ;
Morrison, Daniel R. ;
Clayton, Ellen W. .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2011, 155A (12) :2982-2990
[10]   Biobanking in pediatrics: the human nonsubjects approach [J].
Brothers, Kyle Bertram .
PERSONALIZED MEDICINE, 2011, 8 (01) :71-79